PRESS RELEASE published on 03/10/2023 at 17:00, 3 years 7 months ago Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023
PRESS RELEASE published on 02/28/2023 at 13:30, 3 years 7 months ago Moderna to Present at Cowen's 43rd Annual Health Care Conference
PRESS RELEASE published on 02/23/2023 at 13:00, 3 years 7 months ago Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates
PRESS RELEASE published on 02/22/2023 at 22:05, 3 years 7 months ago Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Mela
PRESS RELEASE published on 02/22/2023 at 13:00, 3 years 7 months ago Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
PRESS RELEASE published on 02/17/2023 at 17:00, 3 years 7 months ago Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
PRESS RELEASE published on 02/16/2023 at 22:05, 3 years 7 months ago Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
PRESS RELEASE published on 02/02/2023 at 13:00, 3 years 8 months ago Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
PRESS RELEASE published on 01/30/2023 at 13:15, 3 years 8 months ago Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
PRESS RELEASE published on 01/17/2023 at 22:05, 3 years 8 months ago Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults
Published on 10/16/2026 at 02:10, 1 hour 32 minutes ago Nova Scotia Silver Explorer TruSilver Metals Corp. Anticipates TSXV Trading Under "TAG" on October 27
Published on 10/16/2026 at 01:45, 1 hour 57 minutes ago Faraday Copper Closes the Acquisition of the San Manuel Project in Arizona and Mobilizes Drill Rigs
Published on 10/16/2026 at 01:30, 2 hours 12 minutes ago LNG Energy Group Announces Closing of Second Tranche of Private Placement
Published on 10/15/2026 at 23:08, 4 hours 34 minutes ago ACCESS Newswire to Present at the 20th Annual LD Micro Main Event XX - Tuesday October 20, 2026 - 11:00AM PT (2:00PM ET)
Published on 10/15/2026 at 23:05, 4 hours 37 minutes ago EXIM Reiterates Target to Finance Approximately 65% of Elk Creek Project Upfront CAPEX
Published on 10/15/2026 at 22:30, 5 hours 12 minutes ago Porsche Mission S: the essence of the sports car reinterpreted
Published on 10/15/2026 at 20:30, 7 hours 12 minutes ago Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 20:28, 7 hours 13 minutes ago EQS-Adhoc: Nordex SE: Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 18:03, 9 hours 39 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:50, 8 hours 52 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 9 hours 57 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 07:27, 20 hours 14 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
